CompoundPreliminary Evidence

D-Mannose

A simple sugar proposed to stop E. coli from sticking to the bladder wall. An early open-label trial suggested it prevents repeat UTIs, but a larger placebo-controlled trial in 2024 found no benefit, and it does not treat an active infection.

At a Glance

Best known for
Studied for preventing repeat UTIs, with mixed results, Well tolerated in trials, Does not act as an antibiotic, so it does not drive antibiotic resistance
Evidence
Preliminary
Typical dose
2 g once daily (the dose used in trials)
Type
Compound

What is D-Mannose?

D-mannose is a naturally occurring simple sugar (hexose monosaccharide) and C-2 epimer of glucose. In lab studies it binds the FimH adhesin on type 1 fimbriae of uropathogenic E. coli, which is the reason it has been tested for preventing urinary tract infections. Whether that lab effect prevents infections in people is not settled.

Known Health Benefits

Studied for preventing repeat UTIs, with mixed results
Well tolerated in trials
Does not act as an antibiotic, so it does not drive antibiotic resistance

How It Works

Uropathogenic Escherichia coli (UPEC) causes 80–90% of UTIs by adhering to mannose receptors on uroepithelial cells via type 1 fimbriae tipped with FimH lectin. In lab models, D-mannose in urine at sufficient concentration occupies the FimH binding sites, so E. coli cannot attach to the bladder wall and are flushed out during urination. This mechanism is highly specific to mannose-binding fimbriae and does not affect commensal bacteria or the gut microbiome. Clinical trials have not consistently shown that this translates into fewer infections. D-mannose is absorbed in the upper GI tract, enters the bloodstream, and is filtered by the kidneys into urine within 30 minutes of ingestion, and stays there for 6–8 hours. Approximately 90% of ingested D-mannose is excreted unchanged in urine. Because most of it is excreted unmetabolized, its effect on blood glucose appears small, though it has not been well studied in people with diabetes.

What Research Says

The evidence is mixed, and the best trial is negative. Kranjčec et al. (World Journal of Urology, 2014) randomized 308 women with recurrent UTIs to D-mannose 2 g a day, nitrofurantoin 50 mg a day, or no prophylaxis for 6 months. Recurrence was 15% with D-mannose, 20% with nitrofurantoin and 61% with nothing. That trial was open-label and had no placebo group. Porru et al. (Journal of Clinical Urology, 2014) was a small pilot crossover study in 60 women. A 2022 Cochrane review of seven small studies concluded there is little to no evidence to support or refute D-mannose for preventing or treating UTIs. The largest and most rigorous test came after that: the MERIT trial (Hayward et al., JAMA Internal Medicine, 2024) randomized 598 women with recurrent UTIs in UK primary care to D-mannose 2 g a day or placebo for 6 months. A further suspected UTI needing a clinic visit occurred in 51.0% with D-mannose and 55.7% with placebo, a difference that was not statistically significant. The authors concluded D-mannose should not be recommended for this purpose. No good trial shows that D-mannose treats an active infection.

Active Compounds

D-mannose

Forms & Bioavailability

D-mannose powder — most economical; dissolves in waterD-mannose capsulesD-mannose + cranberry combinationsD-mannose + probiotic UTI formulas

D-mannose is rapidly absorbed in the upper GI tract and appears in urine within 30 minutes. Approximately 90% is excreted unchanged in urine over 6–8 hours. Blood sugar impact is minimal because D-mannose is not significantly phosphorylated by hexokinase and does not enter glycolysis at meaningful rates.

Dosage Guidance

Use CaseDosage
UTI prevention (recurrent UTIs)2 g once daily (the dose used in trials)
Active UTINo established dose

Always consult a healthcare provider for personalized dosing.

Natural Food Sources

  • Cranberries
  • Apples
  • Oranges
  • Peaches
  • Broccoli
  • Green beans

Potential Side Effects

Loose stools or diarrhea, mostly at higher doses; serious side effects were not reported in trials

Who Should Avoid It

  • Known mannose metabolism disorders (carbohydrate-deficient glycoprotein syndrome)
  • Kidney infection or sepsis (needs urgent medical care and antibiotics)
  • Kidney disease (excretion may be impaired; ask a clinician first)

Pregnancy & Lactation

D-mannose occurs naturally in small amounts in fruit, but supplement doses have not been properly studied in pregnancy or breastfeeding. A UTI in pregnancy always needs prompt medical care and should not be self-treated. Ask your clinician before using it.

Known Drug Interactions

Minimal known interactions

Evidence Classification

Preliminary Evidence

Based on in vitro studies, animal models, pilot trials, or traditional use documentation. Clinical evidence is limited.

Frequently Asked Questions

Does D-mannose work for UTIs?

The evidence is mixed. A 2014 open-label trial of 308 women found fewer repeat UTIs with 2 g a day than with no treatment. The larger MERIT trial in 2024 compared the same dose with placebo in 598 women for 6 months and found no significant difference (51.0% versus 55.7% had another suspected UTI). A 2022 Cochrane review found little to no evidence either way. It has not been shown to treat an infection you already have.

Can D-mannose replace antibiotics for UTIs?

No. D-mannose has not been shown to treat an active UTI, and the best placebo-controlled trial found it did not prevent repeat infections either. See a doctor for UTI symptoms, and get same-day care for fever, chills, back or side pain, vomiting, or blood in your urine, or for any UTI symptoms in pregnancy.

Is D-mannose safe for people with diabetes?

It is a sugar, and although most of it is excreted in urine and its effect on blood glucose appears small, it has not been well studied in people with diabetes. People with diabetes are also more likely to have complicated UTIs that need medical care. Check with your clinician before using it.

Does D-mannose work for UTIs not caused by E. coli?

Its proposed action is specific to E. coli that carry type 1 fimbriae. Infections caused by other bacteria, such as Klebsiella, Proteus or Enterococcus, would not be expected to respond. A urine culture identifies the cause.

How does D-mannose compare to cranberry for UTIs?

Cranberry has the better evidence. A 2023 Cochrane review of 50 trials found cranberry products lowered the risk of repeat UTIs in women with recurrent infections, in children, and in people prone to UTIs after medical procedures. D-mannose has one positive open-label trial and one larger negative placebo-controlled trial. Neither treats an active infection.

References

  1. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. Kranjčec B, Papeš D, Altarac S. World Journal of Urology (2014)View study
  2. Oral D-mannose in recurrent urinary tract infections in women: a pilot study. Porru D, Parmigiani A, Tinelli C, et al.. Journal of Clinical Urology (2014)
  3. D-mannose for UTI prevention: a systematic review. Lenger SM, Bradley MS, Thomas DA, et al.. Neurourology and Urodynamics (2020)View study
  4. D-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women: A Randomized Clinical Trial. Hayward G, et al.. JAMA Internal Medicine (2024)View study
  5. D-mannose for preventing and treating urinary tract infections. Cooper TE, et al.. Cochrane Database of Systematic Reviews (2022)View study

Ranked in our evidence guides

Related Health Conditions

Related Supplements

Have questions about D-Mannose?

Ask Mother Nature AI about dosing, interactions with your medications, whether it fits your health goals, and more — personalized to your health profile.

This entry is for educational purposes only. It is not medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement regimen, especially if you take medications or have health conditions.